Publications by authors named "Alexandra Pedraza"

Claim this Profile
M
Modifying Post-Transplant Cyclophosphamide Platform to Improve Safety in HLA-Matched Allogeneic HCT: A Reduced Dose Plus Adjunctive Strategies.
Filipe R Pinto, María Queralt Salas, María Suárez-Lledó, Alexandra Pedraza, Paola Charry

Transplant Cell Ther· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International Forum on the Use of Irradiated Blood in Patients With Haematological Malignancy: Responses.
Xiao-Yin Zhang, Michael Murphy, Graham P Collins, Vernon J Louw, Gamuchirai Y Tadzimirwa, Alexandra Pedraza

Vox Sang· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International Forum on the Use of Irradiated Blood in Patients With Haematological Malignancy: Summary.
Xiao-Yin Zhang, Michael Murphy, Graham P Collins, Vernon J Louw, Gamuchirai Y Tadzimirwa, Alexandra Pedraza

Vox Sang· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimized GVHD Prevention in HLA-Mismatched Unrelated Allogeneic HCT Using a PTCY-Based Approach.
Filipe R Pinto, María Suárez-Lledó, Laia Guardia, Paola Charry, Joan Cid, Alexandra Pedraza

Eur J Haematol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-Transplant Cyclophosphamide-Based Prophylaxis and Its Impact on Infectious Complications and Immune Reconstitution According to Donor Type.
Beatriz Merchán-Muñoz, María Suárez-Lledó, Luis Gerardo Rodríguez-Lobato, Tommaso Francesco Aiello, Antonio Gallardo-Pizarro, Alexandra Pedraza

Cancers (Basel)· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Applicability and validation of different prognostic scores in allogeneic hematopoietic cell transplant (HCT) in the post-transplant cyclophosphamide era.
María Queralt Salas, Luis Gerardo Rodríguez-Lobato, Paola Charry, Maria Suárez-Lledó, Alexandra Pedraza

Hematol Transfus Cell Ther· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of older adults undergoing allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide based prophylaxis.
Victoria Murillo, Paola Charry, María Suárez-Lledó, Laia Guardia, Cristina Moreno, Alexandra Pedraza

Eur J Haematol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of G-CSF after allogeneic hematopoietic cell transplantation using post-transplant cyclophosphamide: clinical and in vitro examination of endothelial activation.
Silvia Escribano-Serrat, Alexandra Pedraza, María Suárez-Lledó, Paola Charry, Blanca De Moner

Bone Marrow Transplant· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease after Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide: A Study on Behalf of the Spanish Hematopoietic Stem Cell Transplantation and Cellular Therapy Group (GETH).
Ignacio Gómez-Centurión, Ana Isabel Gallardo Morillo, Ariadna Pérez Martínez, Mónica Cabrero Calvo, Anabelle Chinea, Alexandra Pedraza

Transplant Cell Ther· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EASIX and cardiac adverse events after allogeneic hematopoietic cell transplantation.
Carles Tolosa-Ridao, Enric Cascos, Luis Gerardo Rodríguez-Lobato, Alexandra Pedraza, María Suárez-Lledó

Bone Marrow Transplant· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving the EASIX' predictive power for NRM in adults undergoing allogeneic hematopoietic cell transplantation.
Silvia Escribano-Serrat, Luis Gerardo Rodríguez-Lobato, María Suárez-Lledó, Alexandra Pedraza, Paola Charry

Bone Marrow Transplant· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced Dose of Post-Transplant Cyclophosphamide with Tacrolimus for the Prevention of Graft-versus-Host Disease in HLA-Matched Donor Peripheral Blood Stem Cell Transplants: A Prospective Pilot Study.
Alex Juárez, María Queralt Salas, Alexandra Pedraza, María Suárez-Lledó, Luís Gerardo Rodríguez-Lobato

Cancers (Basel)· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Easix Score Correlates With Endothelial Dysfunction Biomarkers and Predicts Risk of Acute Graft-Versus-Host Disease After Allogeneic Transplantation.
Alexandra Pedraza, María Queralt Salas, Luis Gerardo Rodríguez-Lobato, Silvia Escribano-Serrat, María Suárez-Lledo

Transplant Cell Ther· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-Transplantation Cyclophosphamide and Tacrolimus for Graft-versus-Host Disease Prevention after Allogeneic Hematopoietic Cell Transplantation from HLA-Matched Donors Has More Advantages Than Limitations.
María Queralt Salas, Alexandra Pedraza, Paola Charry, María Suárez-Lledó, Luis Gerardo Rodríguez-Lobato

Transplant Cell Ther· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endothelial Activation and Stress Index in adults undergoing allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide-based prophylaxis.
Silvia Escribano-Serrat, Luis Gerardo Rodríguez-Lobato, Paola Charry, Nuria Martínez-Cibrian, María Suárez-Lledó, Alexandra Pedraza

Cytotherapy· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
At-Home Foscarnet Administration in Patients with Cytomegalovirus Infection Post-Allogeneic Stem Cell Transplantation: A Unicentric, Safe, and Feasible Program.
Sonia Ruiz-Boy, Alexandra Pedraza, Marta Prat, Maria Queralt Salas, Esther Carcelero

Pharmaceuticals (Basel)· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential protein expression in endothelial cells exposed to serum from patients with acute graft-vs-host disease, depending on steroid response.
Julia Martinez-Sanchez, Marta Palomo, Alexandra Pedraza, Ana Belén Moreno-Castaño, Sergi Torramade-Moix

J Cell Mol Med· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of CD34 Cell Dose on the Outcomes of Allogeneic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide.
Alexandra Pedraza, María Queralt Salas, Luis Gerardo Rodríguez-Lobato, Paola Charry, María Suárez-Lledo

Transplant Cell Ther· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bacterial Bloodstream Infections in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide.
María Queralt Salas, Paola Charry, Pedro Puerta-Alcalde, Nuria Martínez-Cibrian, María Teresa Solano, Alexandra Pedraza

Transplant Cell Ther· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Low‑risk polycythemia vera treated with phlebotomies: clinical characteristics, hematologic control and complications in 453 patients from the Spanish Registry of Polycythemia Vera.
Ana Triguero, Alexandra Pedraza, Manuel Perez-Encinas, María Isabel Mata-Vazquez, Patricia Vélez

Ann Hematol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Early Intrapatient Variability of Tacrolimus Concentrations on the Risk of Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation Using High-Dose Post-Transplant Cyclophosphamide.
Daniel N Marco, María Queralt Salas, Gonzalo Gutiérrez-García, Inés Monge, Gisela Riu, Alexandra Pedraza

Pharmaceuticals (Basel)· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-risk polycythemia vera treated with phlebotomies: clinical characteristics, hematologic control and complications in 453 patients from the Spanish Registry of Polycythemia Vera.
Ana Triguero, Alexandra Pedraza, Manuel Pérez-Encinas, María Isabel Mata-Vázquez, Patricia Vélez

Ann Hematol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PTCY and Tacrolimus for GVHD Prevention for Older Adults Undergoing HLA-Matched Sibling and Unrelated Donor AlloHCT.
María Queralt Salas, Paola Charry, Alexandra Pedraza, Nuria Martínez-Cibrian, María Teresa Solano

Transplant Cell Ther· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-Dose Cyclophosphamide and Tacrolimus as Graft-versus-Host Disease Prophylaxis for Matched and Mismatched Unrelated Donor Transplantation.
Alexandra Pedraza, Sofia Jorge, María Suárez-Lledó, Arturo Pereira, Gonzalo Gutiérrez-García

Transplant Cell Ther· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defibrotide in hematopoietic stem cell transplantation: A multicenter survey study of the Spanish Hematopoietic Stem Cell Transplantation Group (GETH).
Marta González Vicent, Cristina Díaz de Heredia, Jesús González de Pablo, Blanca Molina, Alexandra Regueiro, Alexandra Pedraza

Eur J Haematol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis